Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. SPY
3. APTX:CN
4. IQMX
5. EROC
6. MSTR
7. TSLA
8. MSFT
9. SEER
10. NVDA

Go back to Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Aviragen Therapeutics (AVIR) Reports Q4 Loss of $0.15/Share

August 31, 2017 4:04 PM EDT

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.15), versus ($0.18) reported last year.

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More